Varian, Inc.

Varian Calypso Anchored Beacon Transponder for Lung Receives FDA 510k Clearance
Communication Systems & Equipment

Varian Calypso Anchored Beacon Transponder for Lung Receives FDA 510k Clearance

PALO ALTO, Calif., April 20, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian TrueBeam®, Edge® and Clinac® C-series medical linear accelerators, the Calypso system and Anchored Beacon transponder detects even slight movements of a tumor and helps clinicians deliver lung...

Read More »
Varian to Showcase Software Solutions for Smarter Cancer Care at HIMSS18
Software

Varian to Showcase Software Solutions for Smarter Cancer Care at HIMSS18

PALO ALTO, Calif., Feb. 26, 2018 - Varian (NYSE: VAR) today announced it will be demonstrating its portfolio of software solutions for smarter cancer care, March 5-8 in Las Vegas, NV at HIMSS18, booth 10518. Varian provides a comprehensive oncology software platform to help manage the entire cancer care process, from diagnosis to survivorship. The Varian solutions being demonstrated at HIMSS18...

Read More »
Software

Varian ARIA Oncology Information System Earns ONC Health IT Certification from Drummond Group LLC

PALO ALTO, Calif., Feb. 22, 2018 - Varian (NYSE: VAR) today announced its ARIA® oncology information system has achieved Office of the National Coordinator for Health Information Technology (ONC-Health IT) 2015 Edition Health IT Module Certification via Drummond Group LLC, an Authorized Certification Body (ACB) that has been empowered to test software for compliance with the requirements of the...

Read More »
Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India
Health, Medical, & Dental Supplies and Equipment

Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India

PALO ALTO, Calif. and MUMBAI, India - Feb. 6, 2018 - Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India. This registration allows Varian to now market this new system in India. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated...

Read More »
Varian Selected to Provide Compact Single-room System for First Proton Therapy Center in Alabama
Health, Medical, & Dental Supplies and Equipment

Varian Selected to Provide Compact Single-room System for First Proton Therapy Center in Alabama

PALO ALTO, Calif., Jan. 24, 2018 - Varian (NYSE: VAR) today announced it has been selected by Proton International to install a Varian ProBeam® Compact single-room proton therapy system in the new University of Alabama at Birmingham Proton Therapy Center. Construction on the new center is expected to begin at the end of January 2018, and first patient treatments are expected to start in early...

Read More »
Varian Halcyon Treatment System Receives Taiwan FDA Approval
Health, Medical, & Dental Supplies and Equipment

Varian Halcyon Treatment System Receives Taiwan FDA Approval

PALO ALTO, Calif., Jan. 8, 2018 - Varian (NYSE: VAR) today announced its Halcyon™ system has received Taiwan FDA approval, which allows the company to market this new cancer treatment system in Taiwan. This approval further expands the global availability of Halcyon and high-quality, cost-effective cancer treatments. As an advanced cancer treatment system with a human-centered and user-friendly...

Read More »
Health, Medical, & Dental Supplies and Equipment

Dissolution Apparatus supports manual and automated testing.

Designed for testing tablets, capsules, and other dosage forms, Model 708-DS features traditional water bath and TruAlign(TM) vessels. System supports several automation options, including automated media temperature sensing, dosage delivery, and sampling. Integration with Varian UV or LC Dissolution Systems accelerates sample analysis, while minimizing potential for sample handling errors.

Read More »
Electronic Components & Devices

Pre-Assembled Cartridges speed oligonucleotide synthesis.

StratoSpheres(TM) DNA Synthesis Cartridges produce small to medium sized oligonucleotide strands required for use in DNA amplification, sequencing, and hybridization. Polystyrene packing provides high-throughput synthesis capabilities, while hydrophobic nature promotes production efficiency by maximizing yield of full length product. Two synthesis scales, 40 and 200 nmol, enable biochemists to...

Read More »
Health, Medical, & Dental Supplies and Equipment

GE Healthcare and Varian, Inc. Announce Pre-Clinical Magnetic Resonance Imaging (MRI) System

PALO ALTO, Calif., May 12 / / - GE Healthcare (NYSE: GE) and Varian, Inc. (NasdaqGS: VARI) announce the availability of the Discovery(TM) MR901, a new pre-clinical 7T magnetic resonance imaging (MRI) system which provides new capabilities for a broad range of research objectives. The Discovery MR901 combines GE Healthcare's state-of-the-art diagnostic technology with Varian's leading scientific...

Read More »
Controls & Controllers

Vacuum Gauge Controller is expandable.

Suited for situations requiring multi-point measurement and tracking of pressure, XGS-600(TM) can operate, display, and process readings from hot filament and cold cathode high-vacuum gauges (including ultra high vacuum) as well as convection roughing gauges. Unit comes in half-rack package and communicates readings/status via serial communications and set-point outputs. Used for data logging and...

Read More »
Company News

Varian Notifies Sirtex it will Not Submit a Counterproposal to Competing Bid

PALO ALTO, Calif., May 22, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it received notice from Sirtex Medical Limited (Sirtex) on May 21, 2018 (Pacific daylight time) that the board of directors of Sirtex has now received a binding proposal (CDH Proposal) from CDH Investments, a China-based alternative asset manager, for the acquisition of all of the issued shares of Sirtex at a...

Read More »
Company News

First Cancer Patients in Korea Treated with Varian HyperArc High-Definition Radiotherapy

PALO ALTO, Calif., May 16, 2018 /PRNewswire/ -- Varian (NYSE: VAR) announced two patients with brain cancer were the first patients in Korea to be treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type of radiosurgery treatment, at the Ajou University Hospital. HyperArc is designed to automate and simplify sophisticated treatments such as stereotactic...

Read More »
Mergers & Acquisitions

Varian Acquires Taiwan Distributor

PALO ALTO, Calif. and TAIPEI, Taiwan, May 7, 2018 /PRNewswire/ -- Varian (NYSE:VAR)  today announced it has acquired  Cooperative CL Enterprises (COOP), a leading distributor of radiotherapy equipment in Taiwan. COOP currently employs 45 people, and has represented Varian in Taiwan for more than 40 years. "With the acquisition of COOP, Varian will be able to work and collaborate more closely...

Read More »
Company News

Varian Notes Receipt of Competing Bid by Sirtex

PALO ALTO, Calif., May 4, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today commented on the press release of Sirtex Medical Limited (Sirtex) dated May 4, 2018 announcing that Sirtex had received an unsolicited non-binding, indicative and conditional proposal from CDH Investments, a China-based alternative asset manager, for the acquisition of all of the issued shares in Sirtex (CDH Proposal).  The...

Read More »
Company News

Varian to Equip New Karolinska Solna Hospital in Sweden with TrueBeam Radiotherapy Systems and Software

PALO ALTO, Calif., April 25, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has signed an agreement with the Stockholm City Council to provide equipment and related services to the radiation therapy department of the New Karolinska Solna (NKS) hospital in Stockholm, Sweden with eight TrueBeam® radiotherapy systems for advanced cancer treatment. The contract for this tender,...

Read More »
Varian Calypso Anchored Beacon Transponder for Lung Receives FDA 510k Clearance
Communication Systems & Equipment

Varian Calypso Anchored Beacon Transponder for Lung Receives FDA 510k Clearance

PALO ALTO, Calif., April 20, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Calypso® Anchored Beacon® transponder. Used with a Varian TrueBeam®, Edge® and Clinac® C-series medical linear accelerators, the Calypso system and Anchored Beacon transponder detects even slight movements of a tumor and helps clinicians deliver lung...

Read More »
Varian to Showcase Software Solutions for Smarter Cancer Care at HIMSS18
Software

Varian to Showcase Software Solutions for Smarter Cancer Care at HIMSS18

PALO ALTO, Calif., Feb. 26, 2018 - Varian (NYSE: VAR) today announced it will be demonstrating its portfolio of software solutions for smarter cancer care, March 5-8 in Las Vegas, NV at HIMSS18, booth 10518. Varian provides a comprehensive oncology software platform to help manage the entire cancer care process, from diagnosis to survivorship. The Varian solutions being demonstrated at HIMSS18...

Read More »
Software

Varian ARIA Oncology Information System Earns ONC Health IT Certification from Drummond Group LLC

PALO ALTO, Calif., Feb. 22, 2018 - Varian (NYSE: VAR) today announced its ARIA® oncology information system has achieved Office of the National Coordinator for Health Information Technology (ONC-Health IT) 2015 Edition Health IT Module Certification via Drummond Group LLC, an Authorized Certification Body (ACB) that has been empowered to test software for compliance with the requirements of the...

Read More »
Mergers & Acquisitions

Varian Acquires Evinance Innovation, Inc.

PALO ALTO, Calif., Feb. 22, 2018 - Varian (NYSE: VAR) today announced it has acquired privately-held Montreal-based Evinance Innovation, Inc., a clinical decision support (CDS) software company. This acquisition expands the capabilities of Varian's 360 Oncology™ care management platform by tightly integrating clinical workflow, decision support, and adherence tracking based on leading...

Read More »
Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India
Health, Medical, & Dental Supplies and Equipment

Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India

PALO ALTO, Calif. and MUMBAI, India - Feb. 6, 2018 - Varian (NYSE: VAR) today announced the Halcyon™ cancer treatment platform has received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India. This registration allows Varian to now market this new system in India. Halcyon simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated...

Read More »

All Topics